Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patients.
Guest
P C
PC
Wang
L
L
Harris
L W
LW
Burling
K
K
Levin
Y
Y
Ernst
A
A
Wayland
M T
MT
Umrania
Y
Y
Herberth
M
M
Koethe
D
D
van Beveren
J M
JM
Rothermundt
M
M
McAllister
G
G
Leweke
F M
FM
Steiner
J
J
Bahn
S
S
D000293:Adolescent; D000328:Adult; D001714:Bipolar Disorder / Q000097:blood; D001786:Blood Glucose / Q000502:physiology; D002096:C-Peptide / Q000097:blood; D053379:Chromogranin A / Q000097:blood; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood; D008297:Male; D009479:Neuropeptides / Q000097:blood*; D011384:Proinsulin / Q000097:blood; D012189:Retrospective Studies; D012559:Schizophrenia / Q000097:blood*; D055815:Young Adult
D001786:Blood Glucose; D002096:C-Peptide; D053379:Chromogranin A; D007328:Insulin; D009479:Neuropeptides; C063879:insulin-related neuropeptide; C070703:proinsulin, des(31,32)-; D011384:Proinsulin